Navigation Links
Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years

FULLERTON, Calif., Oct. 30 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading manufacturer of diagnostics instruments in the U.S., announced that it has been awarded new agreements with Amerinet, Inc., to provide a full range of core laboratory systems and supplies, valued at approximately $74 million per year. Amerinet is one of the nation's largest healthcare group purchasing organizations, with more than 2,200 acute-care hospital members.


Under the terms of the new three-year agreements, Amerinet members will continue to purchase automation, general chemistry, immunoassay, integrated workcells, hematology, flow cytometry, and coagulation products from Beckman Coulter. Beckman Coulter and Amerinet have been partners since 1997.

In making the decision, Amerinet cited Beckman Coulter's ability to deliver resources and solutions that can enhance their members' ability to deliver quality patient care. They also pointed out Beckman Coulter's reputation for quality and responsive service as important to their members' satisfaction.

Leland Mc Arthy, corporate vice president of North America Commercial Operations for Beckman Coulter, said about the contract renewal, "These agreements are a great opportunity to continue to demonstrate our commitment to improving patient health and reducing the cost of care. Our systems simplify and automate laboratory processes, helping to improve the efficiency of Amerinet members."

Systems include Beckman Coulter's market-leading Power Processor Automation Systems and UniCel(R) DxC 800 and DxC 600 Synchron(R) Clinical Systems, as well as high-throughput UniCel DxI 800 Access(R) Immunoassay Systems and integrated UniCel DxC 600i Clinical Systems, which offer one of the broadest menus available today on a single instrument. Cellular analysis systems include state-of-the-art COULTER(R) LH 780 Hematology Analyzers, fully automated ACL* TOP hemostasis systems with optional closed-tube sampling, and the powerful FC 500 Flow Cytometry Systems, the only flow cytometer selected by Amerinet for its members.

About Amerinet, Inc.

Through Total Spend Management Solutions, Amerinet strategically partners with health care providers to improve operating margins by creating efficiencies, reducing costs and identifying new revenue streams. Supported by a team of clinical, data and supply chain experts, Amerinet offers a suite of tools, programs and services including a comprehensive and competitive portfolio that delivers practical solutions to address members' specific needs. Based in St. Louis, Mo, Amerinet serves more than 24,000 acute and non-acute health care providers nationwide. To learn more, visit http://www.amerinet-

About Beckman Coulter, Inc.

Based in Fullerton, California, Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue consisting of supplies, test kits, service and operating-type lease payments represents more than 75 percent of the company's 2006 annual revenue of $2.53 billion. For more information, visit

*ACL is a registered trademark of Instrumentation Laboratory

Contacts: Mary Luthy, Beckman Coulter Robert Raynor, Beckman Coulter

Corporate Communications Investor Relations

(714) 993-8770 (714) 773-7620

SOURCE Beckman Coulter, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Filtration treatment assigns more live kidney donation
2. Depressed women show signs of earlier onset of Perimenopause
3. More signs to an approaching migraine attack
4. An Indian Bride with signs of SARS
5. Recognize Heart Attack Signs
6. Parents Should Look For Signs Of Children Becoming Overweight
7. Early Warning Signs Of Heart Disease
8. Warning Signs On Powered Baby Milk
9. Genetical Screening Can Detect Early Signs Of Multiple Sclerosis
10. Diagnosis of Alzheimers years before clinical signs emerge
11. President and Founder of National Obesity Forum Resigns
Post Your Comments:
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
(Date:6/24/2016)... Las Vegas, Nevada (PRWEB) , ... June 24, ... ... their Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and ... The Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... of the "Structural Electronics 2015-2025: Applications, Technologies, ... In-Mold Electronics, Smart Skin, ... Photovoltaics Structural electronics involves electronic ... load-bearing, protective structures, replacing dumb structures such as ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
Breaking Medicine Technology: